NewcelX Ltd
NCEL
4 hedge funds and large institutions have $743K invested in NewcelX Ltd in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
628% more capital invested
Capital invested by funds: $102K → $743K (+$641K)
0.02% more ownership
Funds ownership: 0% → 0.02% (+0.02%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$951K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$31K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 3 |
Renaissance Technologies
New York
|
-$1.25K |
NCEL Hedge Fund Activity: Q2 2022 in Review
4 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in NewcelX Ltd (NCEL) for Q2 2022, worth a combined $743K — up 628% from $102K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NCEL and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $951K. The largest seller was Citadel Advisors, exiting entirely with an estimated $31K sold.
- 4 institutional investors held NewcelX Ltd (NCEL) as of Q2 2022, down from 5 in Q1 2022.
- Funds reported $743K of NewcelX Ltd stock for Q2 2022, up 628% quarter-over-quarter.
- 1 fund opened new NewcelX Ltd positions in Q2 2022 and 2 closed out, a net change of -1 holder.
- The largest NewcelX Ltd buyer in Q2 2022 was Armistice Capital, an estimated $951K added.
- The largest NewcelX Ltd seller in Q2 2022 was Citadel Advisors, an estimated $31K sold.
Based on aggregated 13F filings for Q2 2022.